Genetic alterations driving HCC development, e.g., TERT promoter, TP53, are rarely found in preneoplastic lesions of HCC (ref. [3–5]), suggesting deregulated expression or functions of signaling molecules contribute to HCC initiation (ref. [2–6]). This evidence concerns the gene TP53 and hepatocellular carcinoma.